Search
Descriptor English: Enoximone
Descriptor Spanish: Enoximona
Descriptor enoximona
Scope note: 1,3-Dihidro-4-metil-5-(4-(metiltio)benzoil)-2H-imidazol-2-ona. Inhibidor selectivo de la fosfodiesterasa, con actividad vasodilatadora e inotrópica positiva que no provoca cambios en el consumo de oxígeno del miocardio. Se utiliza en pacientes con insuficiencia cardiaca congestiva.
Descriptor Portuguese: Enoximona
Descriptor French: Énoximone
Entry term(s): MDL-17,043
MDL-17043
MDL-19,438
MDL-19438
MDL17043
MDL19438
Tree number(s): D03.383.129.308.253
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D017335
Scope note: A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with CONGESTIVE HEART FAILURE.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Cardiotonic Agents
Vasodilator Agents
Phosphodiesterase 3 Inhibitors
Registry Number: C7Z4ITI7L7
CAS Type 1 Name: 2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-
DeCS ID: 30739
Unique ID: D017335
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1993/01/01
Date of Entry: 1992/05/08
Revision Date: 2017/05/24
Énoximone - Preferred
Concept UI M0026327
Preferred term Énoximone
MDL-17,043 - Narrower
Concept UI M0353221
Preferred term MDL-17,043
Entry term(s) MDL-17043
MDL17043
MDL-19,438 - Narrower
Concept UI M0122434
Preferred term MDL-19,438
Entry term(s) MDL-19438
MDL19438



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey